NO-STING SKIN-PREP™ Spray for Periwounds Launched by Smith & Nephew

ST. PETERSBURG, Fla., Sept. 29 /PRNewswire/ -- Today, NO-STING SKIN PREP™ Spray was launched in the U.S. market by the Advanced Wound Management Division of Smith & Nephew (LSE: SN; NYSE: SNN). NO-STING SKIN-PREP Spray is a liquid film-forming dressing that dries in less than 30 seconds for caregiver and patient convenience. The new spray leaves a clear waterproof, breathable and conformable barrier that allows for visual assessment of the periwound area. The new spray formula is alcohol free, reducing the potential for stinging when applied to vulnerable skin.  

NO-STING SKIN-PREP Spray has up to a four day wear time, reducing the need for frequent applications.  The pediatrician tested, hypo-allergenic and latex free formula is suitable for patients of any age whose skin is at risk. It also protects intact and damaged skin from irritation due to digestive secretions, exudate, adhesives, frictional forces, and skin trauma during tape and adhesive removal.

Heidi Hogue, RN, BScN, Director of the Wound Healing Institute of Southeast Arkansas said, "I've been using the NO-STING SKIN-PREP Spray, and the product has exceeded my expectations. I've seen the product perform well when used with Negative Pressure Wound Therapy. I also use it around the periwound areas of pressure, venous and diabetic foot ulcers. NO-STING SKIN PREP Spray is easy to use and it helps me help my patients by preventing and reducing irritation to the skin, and reducing the risk of skin trauma."

"Our new NO-STING SKIN-PREP Spray enhances patient comfort because it is conformable, protects the skin from incontinence and friction, and won't irritate damaged skin," said Tom Dugan, President of North American Wound Management. "For the caregiver, the fast drying spray offers quick and easy application and long lasting products save time and money. NO-STING SKIN PREP Spray can help protect vulnerable skin, reducing the risk of costly infections. The addition of NO-STING SKIN-PREP Spray to our liquid film-forming dressing line and our broad portfolio of trusted wound care brands reflects our commitment to providing solutions that promote positive patient outcomes and cost effective patient care."

NO-STING SKIN-PREP Spray will be featured at the upcoming Clinical Advances in Skin and Wound Care Conference, a national meeting for the interdisciplinary wound care community, taking place September 29 – October 2, 2010, in Orlando, Florida. Try out the new product in person when it is revealed at the Smith and Nephew booth 225, on the Woundcare Walkway, along with Smith & Nephew's broad portfolio of trusted wound care products. Or, contact Smith & Nephew Customer Care (800) 876-1261 for a Smith & Nephew representative in your area to arrange a product demonstration or evaluation. For more about Smith & Nephew, please go to www.smith-nephew.com.

About Smith & Nephew

Smith & Nephew is a global medical technology business with global leadership positions in Orthopaedics; including Reconstruction, Trauma and Clinical Therapies; Endoscopy; including Sports Medicine; and Advanced Wound Management.  Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.

Smith & Nephew is dedicated to helping improve people's lives.  The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust.  The Company has distribution channels, purchasing agents and buying entities in over 90 countries worldwide.  Annual sales in 2009 were nearly $3.8 billion.

Forward-Looking Statements This press release contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act of 1995.  In particular, statements regarding expected revenue growth and trading margins discussed under "Outlook" are forward-looking statements as are discussions of our product pipeline.  These statements, as well as the phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions, are generally intended to identify forward-looking statements.  Such forward-looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the outcome of litigation, claims and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements.  Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20F, for a discussion of certain of these factors.

All forward-looking statements in this press release are based on information available to Smith & Nephew as of the date hereof.  All written or oral forward-looking statements attributable to Smith & Nephew or any person acting on behalf of Smith & Nephew are expressly qualified in their entirety by the foregoing.  Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement contained herein to reflect any change in Smith & Nephew's expectation with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

Trademark of Smith & Nephew.  Certain marks registered US Patent and Trademark Office.

SOURCE Smith & Nephew Advanced Wound Management